Subscribe: Market Wire - Medical and Healthcare: Healthcare
Added By: Feedage Forager Feedage Grade B rated
Language: English
announces  cannabis  clinical  company  marketwired sep  marketwired september  marketwired  media  medical  new  sep  september 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Healthcare

Marketwired - Healthcare

Marketwired - Healthcare

Last Build Date: Thu, 21 Sep 2017 15:05:05 EDT

Copyright: Copyright: (C) Marketwired

Cancer Care Patients and Families Prioritize High-Quality Relationships and Communication

Thu, 21 Sep 2017 14:33:59 EDT

Study in the October issue of The Joint Commission Journal on Quality and Patient Safety

Health Union Launches Online Community

Thu, 21 Sep 2017 14:15:00 EDT

"Atopic Dermatitis In America" Survey Reveals Patient Embarrassment, Frustration

Amazonas Florestal Ltd. Announced Today That the Company's Subsidiary Amazon Hemp Ltd. has Scheduled the Harvest of the First 100-Acre Field for Friday, September 22, 2017

Thu, 21 Sep 2017 14:12:41 EDT

MIAMI, FL--(Marketwired - Sep 21, 2017) - Amazonas Florestal, Ltd. ( (OTC PINK: AZFL), a natural resources company dedicated to innovative, sustainable forest management, industrial CBD hemp and the certification and sales of carbon credits, has announced that as of today, the Company is cleared to harvest the first 100 acre plantation. The Amazonas Florestal management team will be assisting the Amazon Hemp operatives in Colorado throughout the harvesting process, which should be taking place on Friday, September 22, 2017.

Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Thu, 21 Sep 2017 13:51:01 EDT

ESCONDIDO, CA--(Marketwired - Sep 21, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), in conjunction with its joint venture partner, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC PINK: GBHPF), is pleased to provide an update on the hemp cultivation trials conducted in New Brunswick, Canada.

Florida Hospital First to Receive Draeger's Babyleo IncuWarmer Beds, Advancing Prenatal Care in U.S.

Thu, 21 Sep 2017 13:15:11 EDT

Nationally recognized hospital receives innovative NICU technology, helping pre-term babies go home sooner

Medical Innovation Holdings, Inc. (MIHI) Announces Recruitment of Industry Veteran as COO

Thu, 21 Sep 2017 12:18:49 EDT

Enhances leadership team with the recruitment of a senior leader executive in the health and wellness industry

NCQA Releases 2017 Health Insurance Plan Ratings

Thu, 21 Sep 2017 12:02:35 EDT

See Top 10 States with Highest Rated Health Insurance Plans

AngioSoma, Inc. (OTC: SOAN) Reports Esther & Esther Confident in New Revenue Plan

Thu, 21 Sep 2017 11:33:33 EDT

HOUSTON, TX--(Marketwired - Sep 21, 2017) -  AngioSoma, Inc. (OTC: SOAN) -- Esther & Esther management has high optimism that its revenue plan could prove successful. The publicly stated plan simply and efficiently drives high volume traffic and interested buyers directly to

NetworkNewsWire Announces Publication Highlighting The Green Organic Dutchman

Thu, 21 Sep 2017 10:39:52 EDT

NEW YORK, NY--(Marketwired - Sep 21, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring The Green Organic Dutchman ("TGOD"), a client of NNW that produces high-quality, organic medical marijuana.

Eyetronic therapy: New milestone reached with 300 patients treated

Thu, 21 Sep 2017 10:00:00 EDT

Proven optic nerve stimulation can improve field of vision in patients with glaucoma and other optic neuropathies

Streetwise Reports Examines How Possible 'Best-in-Class' Alzheimer's Drug Candidate Offers 'Disruptive' Potential

Thu, 21 Sep 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - September 21, 2017) - André Uddin, an analyst with Mackie Research, explained the rationale for adding this neurodegenerative disease biotech company to his firm's coverage universe.

American Cannabis Company, Inc. Signs Exclusive Distribution Agreement with Earth Alive

Thu, 21 Sep 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Sep 21, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) ("ACC"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has signed an exclusive distribution agreement with Earth Alive, a leading Canadian clean-tech company that develops and manufactures state-of-the-art microbial technology-based products. This agreement allows for the commercialization of Earth Alive's premiere cannabis microbial inoculant product, called Dr. Marijane. Dr. Marijane is a certified organic root probiotic that promotes increased vegetative growth, improves the bioavailability of fertilizer programs, and sustains healthy development and structuring of plant roots.

Westchester Plastic Surgeon Discusses Connection Between Cancer and Male Breast Enlargement

Thu, 21 Sep 2017 08:01:00 EDT

Dr. Neal Goldberg reveals whether gynecomastia can lead to breast cancer in men and how to tell the difference between the two conditions

In-Memory Computing Summit North America 2017 Announces Breakout Session Schedule

Thu, 21 Sep 2017 08:00:00 EDT

Early Bird Registration Discount Rate Ends October 1st

Pharma Competitive Intelligence: Delivering Actionable Insights for Decision Making, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - In a live webinar taking place on Tuesday, October 10, 2017 at 10am EDT (3pm BST/UK) industry experts Jamie Munro, Global Practice Leader of Portfolio and Licensing and Karthik Subramanian, Senior Product Strategy Manager, both from Clarivate Analytics, will provide insight into current Pharma CI, including trends and best practices.

InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Portugal

Thu, 21 Sep 2017 07:30:00 EDT

TEL AVIV, ISRAEL--(Marketwired - Sep 21, 2017) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE American: NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a leading medical distributor in Portugal, to distribute CGuardT EPS (Embolic Prevention System). Medicinália Cormédica MC Medical Lda is a subsidiary of WerfenLife Company, one of Europe's largest distributors of medical products.

Mayo Clinic Doctor Joins Advanced Medical Isotope Corporation's (ADMD) Medical Advisory Board

Thu, 21 Sep 2017 07:22:00 EDT

RICHLAND, WA--(Marketwired - Sep 21, 2017) - Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late stage radiation oncology focused medical device company strengthened its Medical Advisory Board with the recent addition of Dr. Beau Toskich from Mayo Clinic, who has been informally working with the Company's advisory board for the last six months.

Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites, New Webinar Hosted by Xtalks

Thu, 21 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 21, 2017) - It's an exciting time for the life sciences industry, with technology driving greater levels of efficiency, effectiveness and patient engagement and satisfaction in clinical trials.

Fraser Institute News Release: Canada one of highest spenders among universal health-care countries, but ranks near bottom on number of doctors and wait times

Thu, 21 Sep 2017 05:00:00 EDT

VANCOUVER, BC--(Marketwired - September 21, 2017) - Despite spending more on health care than almost every other comparable country with universal health care, Canada ranks near the bottom in the number of physicians and acute care beds -- and suffers from the longest wait times, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

Breathtec Biomedical Announces Resignation of Chief Executive Officer

Wed, 20 Sep 2017 17:05:06 EDT

VANCOUVER, BC--(Marketwired - Sep 20, 2017) -  Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the "Company") announces that effective immediately, Guy La Torre has resigned as Director and Chief Executive Officer ("CEO") of the Company to pursue other ventures. The Company wishes Guy the best with his future endeavours. An interim CEO will be appointed in due course. 

September 30 'Funding Cliff' Threatens Closure of Community Health Centers Nationwide - Open Door Family Medical Centers Takes on Advocacy Role

Wed, 20 Sep 2017 16:42:27 EDT

As Many as 5,000 Open Door patients in Westchester County Could Lose Access to Healthcare

On4 Communications to Expand Sales Force from 4 to 20 and Adds Fly Communictcions Inc to Handle Upcoming Digital Media Needs

Wed, 20 Sep 2017 13:19:30 EDT

NEW YORK, NY--(Marketwired - Sep 20, 2017) - On4 Communications, Inc. (OTC: ONCI) today announced it has expanded its sales force from 4 to 20. We have hired 16 salespeople to sell our entire portfolio of products. These sales people will be in 24 states and their compensation will be 100 % commission based.

SHIEC Elects 2017-2018 Board of Directors

Wed, 20 Sep 2017 10:20:51 EDT

Collaborative Expands Board with Addition of Three New Seats

Blue Diamond Ventures Inc. Secures Canadian Real Estate Project

Wed, 20 Sep 2017 10:01:51 EDT

BLDV will build cannabis cultivation facility for Quality Green Inc. in Ontario

Saavy Naturals Expands Distribution into Major Retailers -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the recent advancements of Trimax Corporation (OTC PINK: TMXN). The company's wholly owned subsidiary, Saavy Naturals Inc., has made tremendous progress over the past few months expanding distribution of its all natural body care line, including its Bay Rum and Hemp product offerings, across major retailers around the world. These developments could help accelerate revenue over the coming quarters and move closer to a breakeven point on a net income basis after achieving positive cash flow this year.

CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s (OTCQB: CNAB) Chief Science Officer Dr. Brent Reynolds, PhD. In the interview, Dr. Reynolds discusses the importance of clinical development and how the company's recent acquisition of Prana Therapeutics plays into its overall strategy.

True Leaf: Crowdfunding Legal Cannabis Products Across North America -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining True Leaf Medicine International Ltd. (CSE: MJ) (CNSX: MJ) (MJ.CN) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf's mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.

ABcann Global Enters Its Growth Phase (Plus Exclusive Interview) -- CFN Media

Wed, 20 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with ABcann Global Corporation's (TSX VENTURE: ABCN) (OTCQB: ABCCF) Aaron Keay, former CEO and current member of the Board of Directors. In the interview, Mr. Keay discusses the company's transition to new CEO Barry Fishman, as well as the opportunities ahead for the company in both Canada and internationally.

Abattis Prepares for Growth in Extracts -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.

Protext Pharma Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance

Wed, 20 Sep 2017 08:30:00 EDT

Company Provides Update on its Cannabis License Application

InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

Wed, 20 Sep 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering how InMed Pharmaceuticals Inc. (CSE: IN) (CNSX: IN) (IN.CN) (OTCQB: IMLFF) is leveraging biosynthesis to solve a major problem in the medical cannabis industry as it adds key ex-Eli Lilly personnel to its efforts.

Melissa Asserts Better Data Equals a Great Customer Experience

Wed, 20 Sep 2017 08:00:00 EDT

Consumer Data Enhancements Personalize Online Shopping in Real-Time; Global Intelligence Solutions Demonstrated at

HemCare Health Services Appoints Telecom Veteran Daniel G. Cullen as Chief Technology Officer

Wed, 20 Sep 2017 08:00:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 20, 2017) - HemCare Health Services Inc. (OTC PINK: HCRE) is pleased to announce the appointment of Daniel G. Cullen as Chief Technology Officer. Mr. Cullen will be responsible for HemCare Health Services technology strategy and execution. In this capacity he will lead the company's engineering and software development team and spearhead the company's new technology initiatives in the application of Blockchain technology. Mr. Cullen will report directly to John Wilkes, CEO of Hemcare.

GrayMeta Partners with Levels Beyond to bring Artificial Intelligence Across Media Workflows

Wed, 20 Sep 2017 08:00:00 EDT

THOUSAND OAKS, CA--(Marketwired - Sep 20, 2017) - GrayMeta, a leading provider of professional media players and metadata solutions for content owners, and Levels Beyond, creators of the software platform Reach Engine which enables companies to create and curate video content in sync with media workflows, today announce that their services are fully integrated and able to deliver automated metadata extraction and creation. The partnership will enable content owners to adopt cutting-edge AI technology via GrayMeta Platform automation -- quickly creating comprehensive, searchable insights for content within Reach Engine.

Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor

Wed, 20 Sep 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - Sept. 20, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry.

Strategy Design & Formulation Considerations for GLP Toxicology Studies, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - A lack of planning for a new compound's GLP toxicology study can severely trip up your IND. Upfront planning to design a successful toxicology study, identify problems and allow time for solutions can help avoid costly delays. Toxicology study design requires a customized strategy that is relevant to the intended clinical indication and route of administration and is acceptable to regulatory authorities. Formulation development plays an important role in assessing the in-vivo properties of a molecule during preclinical development, such as overcoming solubility issues and maximizing exposure.

Milestone Scientific's CompuFlo(R) Epidural Instrument Featured in Abstract Presented at the 36th Annual Congress of The European Society of Regional Anaesthesia & Pain Therapy

Wed, 20 Sep 2017 07:30:00 EDT

LIVINGSTON, NJ--(Marketwired - September 20, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) a leading medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that an abstract featuring the CompuFlo® epidural instrument was presented on September 13, 2017 at the 36th Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) Congress 2017, in Lugano, Switzerland. The European Society of Regional Anesthesia & Pain Therapy has a current membership of over 3,500 of the leading anesthesiologists in Europe.

Portland Taps Napoli Shkolnik To Join Nationwide Opioid Lawsuit

Wed, 20 Sep 2017 07:30:00 EDT

NEW YORK, NY--(Marketwired - September 20, 2017) - Maine's largest city selected the New York City-based litigation firm to help offset the "massive damages" that the heroin addiction epidemic has caused in and around the city of Portland, according to City Attorney Danielle West-Chuhta. The move guarantees the city a substantial portion of any future settlement or judgment, and Napoli Shkolnik attorney Paul Napoli said his firm waived all upfront legal fees and costs in the matter.

Next Generation Data Mapping and Analytics Solutions Improve the Speed and Quality of Preparing Data Submissions for FDA, New Webinar Hosted by Xtalks

Wed, 20 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 20, 2017) - FDA now requires drug development firms pursuing approvals to submit all clinical data in CDISC standards such as the Study Data Tabulation Model (SDTM). To meet this requirement, many companies are using labor-intensive, manual and error-prone data extraction and mapping techniques.

Fraser Institute Media Advisory: How does Canada's health-care system compare to other universal systems around the world? New study coming Thursday, Sept. 21

Wed, 20 Sep 2017 07:00:00 EDT

VANCOUVER, BC--(Marketwired - September 20, 2017) - On Thursday, Sept. 21, the Fraser Institute will release a new study on health care.

Dr. Ellen Turner, Dermatologist in Dallas, TX, To Feature "Best of 2017" Treatments in Exclusive October Showcase

Tue, 19 Sep 2017 18:30:00 EDT

As part of her efforts to continually educate patients and provide them with the most effective treatment protocols that cosmetic dermatology has to offer, dermatologist Dr. Ellen Turner is hosting "Showcase Showdown" at her Dallas practice on Oct. 26, 2017

Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."

FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs

Avadim Technologies Inc. Announces Partnership With Cardinal Health, Inc.

Tue, 19 Sep 2017 09:15:00 EDT

Cardinal Health, a Global, Integrated Healthcare Services and Products Company Ranked #15 of Fortune 500 Companies, Will Now Supply Theraworx(R) Technology to its Acute Care and Long-Term Care Customers

Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.

Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th

Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.

Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.

Melissa Offers Active Data Quality Deployment Strategies at Microsoft Ignite

Tue, 19 Sep 2017 08:00:00 EDT

Defining the Data Quality Edge Drives Build vs Buy Decisions; Consultative Strategies and Tools Demonstrated

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration

Tue, 19 Sep 2017 08:00:00 EDT

Novel Injectable Formulation for Potential Twice Per Year Treatment

Pharmacology to Payer: One Quantitative Drug Development Framework to Rule Them All

Tue, 19 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - This webinar will discuss how "pharmacology to payer" (P2P) can be used as a quantitative framework that bridges the disciplines of pharmacology, epidemiology, and health economics to support meaningful dialogue between industry, regulators, and payers.

Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic agents.

MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

Tue, 19 Sep 2017 05:21:20 EDT

HONG KONG, CHINA--(Marketwired - Sep 19, 2017) - MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage has historically been a challenge. MetLife Hong Kong's inclusive action will make medical protection more accessible to this group of people.

DIGX Continues to Develop Strategic Growth Plan

Mon, 18 Sep 2017 17:41:43 EDT

DALLAS, TX--(Marketwired - Sep 18, 2017) - Dig-it Underground, Inc. (OTC PINK: DIGX) recently unveiled part of its strategic growth plan as the Company continues to move forward at a tremendous pace. While the Company is obviously very excited about its record year to date revenue, the Company is not satisfied and is focused on continuing the momentum and taking the Company to unprecedented heights. 

FRDJ et la Financière Sun Life font équipe pour amasser des fonds destinés à la recherche sur le diabète

Mon, 18 Sep 2017 16:33:42 EDT

La Révolution FRDJ Roulons met les Canadiens au défi de se dépasser et de récolter de l'argent pour vaincre le diabète de type 1

JDRF and Sun Life Financial team up to raise funds for diabetes research

Mon, 18 Sep 2017 16:33:07 EDT

The JDRF Revolution Ride challenges Canadians to go further and raise funds to defeat type 1 diabetes

Medigus Announces Second Quarter 2017 Financial Results

Mon, 18 Sep 2017 16:05:00 EDT

OMER, ISRAEL--(Marketwired - Sep 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2017.

The Green Organic Dutchman Holdings Ltd. Announces Financing Syndicate for $20 Million Offering

Mon, 18 Sep 2017 15:58:58 EDT

HAMILTON, ON--(Marketwired - September 18, 2017) -

Players Network, Inc. Third Quarter Shareholder Update

Mon, 18 Sep 2017 09:47:48 EDT

PNTV prepares to launch WeedTV, Multi-Million Dollar Financing Commitment, Green Leaf Farm Revenues, Building a Core Management Team and more

Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

Mon, 18 Sep 2017 09:46:37 EDT

Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year

2017 Letter to Shareholders From the Chairman, President and CEO

Mon, 18 Sep 2017 09:00:00 EDT

BOCA RATON, FL--(Marketwired - Sep 18, 2017) - EXOlifestyle, Inc. (OTCQB: EXOL)

GeoVax Provides Update on its Zika Vaccine Development

Mon, 18 Sep 2017 09:00:00 EDT

Presentation Made During 11th Vaccine Congress in San Diego

Call for Nominations for the Best Benefits Practices and the Rising Star Awards

Mon, 18 Sep 2017 08:00:00 EDT

Raise your company's profile with an award from the region's leading provider of benefits education

MediXall Group, Inc. Creates Multiple Revenue Streams in September 2017

Mon, 18 Sep 2017 08:00:00 EDT

FT. LAUDERDALE, FL--(Marketwired - Sep 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) announced today that three additional revenue streams are in place and operational, creating additional value in the company. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. Prior to the planned October launch of the MediXaid Healthcare Platform, a subsidiary of MediXall Group with over 3,500 practitioners and diagnostic centers participating, to date, the company has signed agreements with strategic partners, SafeRide and PWeR®, who offer strong solutions to help network practitioners grow their businesses.

Tetra Bio-Pharma getting ready to file a clinical trial application to initiate phase 3 clinical trial on terminal cancer patients in the coming weeks

Mon, 18 Sep 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - Sept. 18, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), today announces that it will be filing a clinical trial application (CTA) in the coming weeks to therapeutic products directorate (TPD) to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients. With this filing, Tetra expects to be on time with its previously announced schedule with the development of PPP001. The corporation worked with physicians of Sante Cannabis to design a clinical trial that would demonstrate the safety and efficacy of PPP001 in terminal cancer patients. In addition, as part of the clinical trial, Tetra will collect the pharmacoeconomics evidence required from provincial insurers in order to support the reimbursement of the first cannabis prescription drug.

Titan Medical and Florida Hospital Nicholson Center Announce the World's First Installation of Sport Surgical System

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), and Florida Hospital Nicholson Center announce the installation of Titan Medical's SPORT Surgical System at the hospital's training facility in Celebration, Florida. This is the first installation in the world for pre-clinical feasibility and validation studies of the SPORT Surgical System, a single port robotic system.

What Does it Take to Successfully Execute Large, Global, Phase III Programs?

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In a complimentary webinar taking place on Tuesday, October 3, 2017 at 10am EDT (3pm BST/UK), INC Research/inVentiv Health leaders Clifford McIntosh, Vice President of Strategic Alliance Management and Alexandria Wise-Rankovic, Ph.D., Senior Vice President of Clinical Development, CNS reveal a proven method to thrive in large, global, Phase III Programs.

Why Track and Trace Isn't Just Tracking and Tracing: Best Practices for Implementing a Solution That Works

Mon, 18 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In an upcoming webinar on Wednesday, October 4, 2017, industry expert Joe Lipari, Director of Cloud Products at Systech International will discuss a holistic approach towards designing and achieving a successful Track and Trace solution.

On4 Communications Announces a 73.6% Increase in Revenue Over 2nd Quarter

Fri, 15 Sep 2017 16:51:05 EDT

NEW YORK, NY--(Marketwired - Sep 15, 2017) - On4 Communications, Inc. (OTC: ONCI) today announced it has released its financials with a 73.6% increase in revenue over 2nd Quarter.

Daxor Corporation Forwarding Plans to Expand Impact at HFSA 2017 and Beyond

Fri, 15 Sep 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - Sep 15, 2017) - Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced today that it will be exhibiting at the 21st meeting of the Heart Failure Society of America (HFSA) in Dallas, Texas, from September 16 through September 18, 2017, at booth 517. HFSA is well recognized as an outstanding forum for the presentation of the latest information on clinical and basic research, treatment and patient care in heart failure (HF), and is attended by key thought leaders and decision makers in the field.

Chiesi Salutes Nurses on Neonatal Nurses Day 2017

Fri, 15 Sep 2017 09:00:00 EDT

Neonatal nurses celebrated by colleagues and Chiesi for their commitment to babies

Canada House Wellness Group Announces Issuance of Management Cease Trade Order

Fri, 15 Sep 2017 08:30:00 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 15, 2017) -

Lugano 2014 Criteria for Assessing FDG-PET/CT in Lymphoma: An Operational Approach for Clinical Trials

Fri, 15 Sep 2017 08:15:21 EDT

The goal of this webinar hosted by Xtalks is to discuss the evolution of the role of imaging in the assessment of lymphomatous disease

Development and Manufacture of HPAPI Drug Products through the Clinical Phases from molecule to market, New Webinar Hosted by Xtalks

Fri, 15 Sep 2017 08:12:31 EDT

TORONTO, ON--(Marketwired - September 15, 2017) - This webinar will share how highly potent APIs can be developed and manufactured into suitable drug dosage forms including; solid oral, non-sterile oral liquids and semi-solid creams and ointments whilst adhering to the highest quality standards. Attendees will learn about the complexities at each stage of the development lifecycle, from the earliest phase of First in Man (FiM) studies involving drug in capsule, moving through ongoing clinical development and process optimization of often complex formulations ultimately resulting in commercialization and global supply.

Most Surveyed Pharma Companies Choose to Fund Dedicated Continuing Medical Education Programs

Thu, 14 Sep 2017 18:51:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2017) - About 77% of surveyed global medical affairs teams consider dedicated CME providers as their first choice when funding continuing medical education (CME) programs, according to a recent study by industry intelligence provider, Cutting Edge Information.

Dr. Naomi Brooks, Board-Certified Dermatologist in Boise, ID, Announces Her Practice's Sept. 26 Grand Opening

Thu, 14 Sep 2017 18:00:00 EDT

Boise Dermatology in Idaho provides information and patient resources about medical and cosmetic dermatological treatments and self-care advice on its website that went live in August